首页> 美国卫生研究院文献>Public Health Action >Tuberculosis among migrants in Bishkek the capital of the Kyrgyz Republic
【2h】

Tuberculosis among migrants in Bishkek the capital of the Kyrgyz Republic

机译:吉尔吉斯共和国首都比什凯克的移民中的结核病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Setting: Twenty-two first-line, two second-line and one tertiary health facility in Bishkek, the capital of Kyrgyzstan.>Objectives: Among migrants, a marginalised population at risk for acquiring and transmitting tuberculosis (TB), we determined the proportion with TB among all registered TB cases. For those registered at primary-level facilities, we then reported on their demographic and clinical profiles and TB treatment outcomes.>Design: This was a retrospective cohort analysis of 2012–2013 programme data.>Results: Of 2153 TB patients registered in all health facilities, 969 (45%) were migrants, of whom 454 were registered in first-line facilities. Of these, 27% were cross-border migrants, 50% had infectious TB and 12% had drug-resistant TB. Treatment success was 74% for new cases and 44% for retreatment TB (the World Health Organization target is ⩾85%). Failure in new and retreatment TB patients was respectively 8% and 25%. Twenty-six individuals started on a first-line anti-tuberculosis regimen failed due to multidrug-resistant TB. Eight (25%) of 32 individuals on a retreatment TB regimen also failed. Loss to follow-up was 10% for new and 19% for retreatment TB.>Conclusion: Migrants constituted almost half of all TB patients, drug resistance is prevalent and treatment outcomes unsatisfactory. Fostering inter-country collaboration and prioritising rapid TB diagnostics (Xpert® MTB/RIF) and innovative ways forward for improving treatment outcomes is urgent.
机译:>环境:吉尔吉斯斯坦首都比什凯克的22线第一线,2线第二线和1线三级医疗机构。>目标:在移民中,处于边缘化边缘的人口处于危险之中为了获取和传播结核病,我们确定了所有登记的结核病病例中结核病的比例。然后,对于在基层医疗机构注册的人员,他们报告了他们的人口统计学和临床​​概况以及结核病治疗结果。>设计:这是对2012-2013年计划数据的回顾性队列分析。>结果: 在所有医疗机构中注册的2153 TB患者中,有969名(占45%)是移民,其中454名在一线机构中注册。其中,27%为跨境移民,50%为传染性结核病,12%为耐药结核病。新病例的治疗成功率为74%,结核再治疗的成功率为44%(世界卫生组织的目标是⩾85%)。新发结核病和再治疗结核病患者的失败率分别为8%和25%。二十六名患者因抗多药结核病而开始接受一线抗结核治疗失败。接受结核再治疗的32名患者中有8名(25%)也失败了。结论:移民在所有结核病患者中几乎占一半,耐药性普遍存在,治疗效果不理想。>结论:加强国家间合作并优先考虑快速结核病诊断(Xpert ® MTB / RIF)和创新方法以改善治疗效果是迫在眉睫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号